Dermatomyositis Protective for Some Aspects of COVID-19
COVID-19 outcomes in patients with dermatomyositis are compared with those of the general population.
Dermatomyositis
EULAR/ACR Criteria Misses 30% of Patients With Anti-MDA5-Related Idiopathic Inflammatory Myopathy
Researchers evaluated the performance of the 2017 EULAR/ACR classification criteria in a cohort of patients with MDA5-associated idiopathic inflammatory myopathy (IIM).
Clinical and Histopathologic Features of Dermatomyositis and MDA5 Autoantibody Seropositivity Status Studied
Researchers evaluated clinical and histopathologic features in patients with dermatomyositis and circulating MDA5 autoantibodies, as defined by commercial-based testing.
Immune Globulin Intravenous (Human) 10% Approved for Adult Dermatomyositis
The approval was based on data from the ProDERM study, which evaluated the efficacy and safety of Octagam 10% in 95 adults with dermatomyositis.
Phase 3 Trial Shows Intravenous Immunoglobulin Therapy Safe and Effective for Adult Patients With Dermatomyositis
In a study presented at the EULAR 2021 Virtual Congress, researchers evaluated the safety and efficacy of intravenous immunoglobulin therapy in adult patients with dermatomyositis.
Case Report: Hepatosplenic T-Cell Lymphoma in Dermatomyositis Treated With Prednisolone, Azathioprine
This is the first report of hepatosplenic T-cell lymphoma in a patient with dermatomyositis treated with prednisolone and azathioprine.
Integrating Clinical and Laboratory, Biopsy Findings May Help Predict Prognosis of Juvenile Dermatomyositis
Researchers assessed clinical features, muscle biopsy scores, and myositis-specific antibody profiles in juvenile dermatomyositis, and their association with disease outcomes and treatment responses in patients.
Creatine Supplementation May Be Safe, Well Tolerated in Patients With Juvenile Dermatomyositis
Researchers aimed to evaluate the feasibility of studying creatine in juvenile dermatomyositis and to determine the effect of creatine on muscle function and metabolism.
Using Myositis-Specific Antibodies to Identify Phenotypic Subgroups of Juvenile Dermatomyositis
Study authors investigated the link between anti-P155/140 and lipodystrophy, and between anti-P155/140 and damage to the nailfold capillary system in children with juvenile dermatomyositis.
Evidence Supports Content Validity of Patient-Reported Outcome Measures in Inflammatory Myositis
Researchers investigated the content validity of patient-reported outcome measures in patients with idiopathic inflammatory myopathies.
- Loading...
Loading...
Next post in Inflammatory Myopathy
Loading... 
Loading...